Genprex Ownership | Who Owns Genprex?
Genprex Ownership Summary
Genprex is owned by 2.52% institutional investors, 0.25% insiders, and 97.24% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.30% of its assets in Genprex shares.
GNPX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Genprex | 2.52% | 0.25% | 97.24% |
Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 23 | 4.55% | 384,531 | 32.04% | 2 | 35.03% | 13 | 30.00% | 2 | -50.00% |
Dec 31, 2024 | 22 | 10.00% | 291,226 | 33.34% | 2 | 6.89% | 10 | -23.08% | 4 | 100.00% |
Sep 30, 2024 | 20 | 42.86% | 218,409 | -19.32% | 6 | 3.98% | 13 | 85.71% | 2 | - |
Jun 30, 2024 | 14 | -6.67% | 270,707 | 89.37% | 12 | 16.04% | 7 | 75.00% | 2 | -81.82% |
Mar 31, 2024 | 15 | -54.55% | 142,949 | -96.67% | 8 | 14.32% | 4 | -75.00% | 11 | 266.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 54.80K | 0.30% | 4.11K |
Spartan Extended Market Index Pool E | 13.66K | 0.08% | 442.00 |
Fidelity Series Total Market Index | 12.72K | 0.07% | 3.10K |
Vanguard Institutional Extnd Mkt Idx Tr | 14.97K | 0.06% | - |
Spartan Extended Market Index Pool F | 13.66K | 0.06% | 442.00 |
Fidelity Nasdaq Composite Index | 879.00 | 0.03% | - |
SSgA U.S. Extended Market Index Class I | 15.80K | 0.02% | - |
Fidelity Total Market Index | 1.70K | 0.01% | - |
EC SICAV EverCapital Invms UCITS I Ins I | 1.50K | 0.01% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.01K | 0.01% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 21, 2023 | Varner John Rodney | Chairman, President and CEO | Buy | $20.05K |
Apr 21, 2023 | VACZY CATHERINE M | EVP GC Chief Strategy Officer | Buy | $21.48K |
Apr 05, 2021 | LONGNECKER BRENT M | - | Buy | $62.25K |
Sep 05, 2019 | Varner John Rodney | Chief Executive Officer | Buy | $1.59K |
Jul 30, 2018 | Pham Julien L | President & COO | Buy | $1.70K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | - |
2023 Q2 | 2 | - |
2023 Q1 | - | - |
2022 Q3 | - | - |
GNPX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools